Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases
暂无分享,去创建一个
K. Blennow | L. Minthon | N. Bogdanovic | H. Zetterberg | A. Wallin | N. Andreasen | I. Skoog | D. Gustafson | S. Nilsson | H. Nissbrandt | M. Zetterberg | S. Landgren | A. Håkansson | G. Tasa | Malin von Otter | Caroline Lundvall
[1] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[2] Á. J. Láruson,et al. Genetic Variation , 2020, Population Genetics with R.
[3] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[4] H. Vankova. Mini Mental State , 2010 .
[5] E. Eriksson,et al. PITX3 polymorphism is associated with early onset Parkinson's disease , 2010, Neurobiology of Aging.
[6] Thomas W. Mühleisen,et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2009, Nature Genetics.
[7] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[8] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[9] Andrew J. Saykin,et al. Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.
[10] Concepción Lillo,et al. Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin-1 Transport Defects , 2009, The Journal of Neuroscience.
[11] A. Kondacs,et al. Gene-environmental effects behind leukoaraiosis: a silent genetic variant of the kinesin protein can be activated in a subject with poorly controlled long-lasting hypertension. , 2009, Clinical biochemistry.
[12] V. Pankratz,et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.
[13] Eden R Martin,et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.
[14] K. Doheny,et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.
[15] S E Poduslo,et al. Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[16] Christoph Lange,et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.
[17] Mostafa Ronaghi,et al. Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease , 2008, Human mutation.
[18] O. Sydow,et al. Cerebellar αsynuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] S. Cichon,et al. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling , 2008 .
[20] Nobutaka Hirokawa,et al. Intracellular Transport and Kinesin Superfamily Proteins, Kifs: Structure, Function, and Dynamics , 2022 .
[21] K. Taylor,et al. Genome-Wide Association , 2007, Diabetes.
[22] A. Kondacs,et al. A Cytoskeleton Motor Protein Genetic Variant May Exert a Protective Effect on the Occurrence of Multiple Sclerosis: The Janus Face of the Kinesin Light-Chain 1 56836CC Genetic Variant , 2007, NeuroMolecular Medicine.
[23] K. Blennow,et al. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease. , 2007, International journal of molecular medicine.
[24] A. Kondacs,et al. A Genetic Variant in Cytoskeleton Motors Amplifies Susceptibility to Leukoaraiosis in Hypertensive Smokers: Gene–Environmental Interactions Behind Vascular White Matter Demyelinization , 2007, Journal of Molecular Neuroscience.
[25] K. Blennow,et al. Variability in the kinesin light chain 1 gene may influence risk of age-related cataract , 2007, Molecular vision.
[26] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[27] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[28] M. Gill,et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.
[29] R. Llinás,et al. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C , 2007, Proceedings of the National Academy of Sciences.
[30] Sonja W. Scholz,et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.
[31] F. Scholz. Maximum Likelihood Estimation , 2006 .
[32] Christopher Sorensen,et al. Role of short-range protein interactions in lens opacifications. , 2006, Molecular vision.
[33] R. Carrell. Cell toxicity and conformational disease. , 2005, Trends in cell biology.
[34] Mariza de Andrade,et al. High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.
[35] W. Noble,et al. Molecular motors implicated in the axonal transport of tau and α-synuclein , 2005, Journal of Cell Science.
[36] E. Masliah,et al. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.
[37] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[38] Bin Zhang,et al. Axonal transport defects: a common theme in neurodegenerative diseases , 2005, Acta Neuropathologica.
[39] H. Kao,et al. Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation. , 2004, Molecular vision.
[40] A. Delacourte,et al. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease , 2004, Neuroscience Letters.
[41] L. Goldstein,et al. Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction. , 2004, Current opinion in cell biology.
[42] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[43] W. Lo,et al. Microtubule configuration and membranous vesicle transport in elongating fiber cells of the rat lens. , 2003, Experimental eye research.
[44] L. Goldstein,et al. Do Disorders of Movement Cause Movement Disorders and Dementia? , 2003, Neuron.
[45] J. Rothnagel,et al. Alternatively Spliced Products of the Human Kinesin Light Chain 1 (KNS2) Gene , 2003, Traffic.
[46] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[47] L. Goldstein,et al. Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP , 2001, Nature.
[48] L. Goldstein,et al. Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.
[49] K. Blennow,et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.
[50] C. Kaether,et al. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. , 2000, Molecular biology of the cell.
[51] K. Blennow,et al. Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[52] K. Livak,et al. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.
[53] K. Blennow,et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.
[54] L. Excoffier,et al. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.
[55] K. Kosik,et al. Inhibition of Kinesin Synthesis In Vivo Inhibits the Rapid Transport of Representative Proteins for Three Transport Vesicle Classes into the Axon , 1995, Journal of neurochemistry.
[56] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[57] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[58] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[59] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[60] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[61] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[62] W. Noble,et al. Molecular motors implicated in the axonal transport of tau and alpha-synuclein. , 2005, Journal of cell science.
[63] B. Winblad,et al. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis , 2004, Acta Neuropathologica.
[64] E. Kosno-Kruszewska,et al. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease. , 2003, Folia neuropathologica.
[65] L. Feuk,et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. , 2001, Genome research.
[66] A. Lees,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.
[67] Lees Aj,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993 .